AH Capital Management’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
AH Capital Management's SCTX Position: Q3 2026 in Review
AH Capital Management opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 3,082,725 shares worth $56.7M. The stake represents 0.29% of the portfolio and ranks #8 among its holdings.
62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- AH Capital Management held 3,082,725 shares of Scribe Therapeutics worth $56.7M as of Q3 2026.
- Scribe Therapeutics was a new AH Capital Management position in Q3 2026.
- Scribe Therapeutics made up 0.29% of AH Capital Management's portfolio in Q3 2026, its #8 holding.
- 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on AH Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.